The reclassification of marijuana will change the way researchers will be able to study the drug, Dr. Kathryn Cunningham told the Daily News for a story on the U.S. Justice Department’s move to reclassify marijuana as a less dangerous drug. “By reducing it to Schedule III, we would facilitate the research and allow laboratories to gain much more information and knowledge about the impact of marijuana and its constituents on public health,” Cunningham said.

In January 2024, we unveiled an upgraded website dedicated to facilitating communication and information sharing for the Center for Addiction Sciences and Therapeutics (CAST). Formerly known as The Center for Addiction Research (CAR), which was established in 2004 as a key institutional center promoting discovery and translational research in addictive processes, CAST underwent a rebranding in 2023.

Created as a coordinating force for research in the etiology and pathophysiology of addiction, CAR's success prompted a name change to the Center for Addiction Sciences and Therapeutics (CAST) in spring 2023. This rebranding highlights our commitment to treating addiction as a disease, showcasing breakthrough scientific approaches in overcoming neuropsychiatric disorders, and emphasizing that our discoveries are paving the way for innovative therapeutics. Ultimately, our mission is to provide hope, save lives, and enhance productivity through impactful scientific advancements. Explore the new CAST website to stay informed and engaged with our transformative work.